Form 4: Tandem Diabetes Care Director Joao Paulo Falcao Malagueira Reports Stock Transactions

Sentiment:

SEC Form 4


Director Joao Paulo Falcao Malagueira reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Summary

  • On May 24, 2024, Joao Paulo Falcao Malagueira, a director of Tandem Diabetes Care Inc., reported transactions involving the company's stock.
  • Malagueira acquired 4,065 shares of common stock through the vesting of restricted stock units at a price of $51.73 per share.
  • Following these transactions, Malagueira directly owns 5,814 shares of Tandem Diabetes Care Inc.
  • Malagueira also holds 4,387 restricted stock units, which will vest on the one-year anniversary of the grant date of May 22, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the healthcare and medical device industry.

Key Dates

DateDescription
05/22/2024Restricted stock units (4,387) awarded to Joao Paulo Falcao Malagueira.
05/24/2023Restricted stock units (4,065) awarded to Joao Paulo Falcao Malagueira.
05/24/2024Joao Paulo Falcao Malagueira acquired 4,065 shares of common stock through the vesting of restricted stock units and disposed of 4,065 shares.
05/24/2024Date of report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.